Elemind

About Elemind

Elemind is a company focused on wearable neurotechnology designed to enhance sleep performance. Their mission is to help users fall asleep faster and achieve deeper, more efficient sleep through innovative, drug-free solutions using real-time brainwave modulation.

Products & Services

Elemind Headband:A wearable neurotechnology device for sleep that measures and responds to individual brainwaves using EEG signals and acoustic stimulation. Clinically shown to help 76% of users fall asleep significantly faster, improve sleep efficiency, and restart sleep on-demand. Priced at $349 with a 30-day money-back guarantee.

Specialties

Real-time brainwave modulation Wearable sleep technology Drug-free sleep solutions AI-driven sleep optimization Neuromodulation

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Seed T: - FT: Seed	A: 12000000 MR: - FA: $12M FAN: 12000000	D: 2024-02-06 FD: 2024-02-06	12 investors

Seed Latest

2024-02-06

$12.0M

12 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

D

Deepak Chopra

M

Meredith Perry

Co-Founder + CEO

E

Ed Boyden

Co-Founder and Professor of Neurotechnology at MIT

N

Nir Grossman

Co-Founder

D

David Wang

Co-Founder + CTO

H

Heather Read

Co-Founder + Science Advisor

View 15 more team members with Pro

Unlock Full Team Directory

Recent News

Elemind Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised